Samuel McLenachan

1.5k total citations
77 papers, 1.1k citations indexed

About

Samuel McLenachan is a scholar working on Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Samuel McLenachan has authored 77 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 28 papers in Ophthalmology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Samuel McLenachan's work include Retinal Development and Disorders (40 papers), CRISPR and Genetic Engineering (27 papers) and Retinal Diseases and Treatments (21 papers). Samuel McLenachan is often cited by papers focused on Retinal Development and Disorders (40 papers), CRISPR and Genetic Engineering (27 papers) and Retinal Diseases and Treatments (21 papers). Samuel McLenachan collaborates with scholars based in Australia, Spain and United Kingdom. Samuel McLenachan's co-authors include Fred K. Chen, Ann M. Turnley, Yona Goldshmit, Paul G. McMenamin, Dan Zhang, Michael J. Edel, Elizabeth Rakoczy, Holly R. Chinnery, Panos Ioannou and Xiangting Chen and has published in prestigious journals such as PLoS ONE, Brain Research and International Journal of Molecular Sciences.

In The Last Decade

Samuel McLenachan

74 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel McLenachan Australia 20 575 374 216 203 152 77 1.1k
Inge Van Hove Belgium 22 596 1.0× 477 1.3× 305 1.4× 150 0.7× 295 1.9× 38 1.4k
Zhongshu Tang China 20 593 1.0× 176 0.5× 234 1.1× 82 0.4× 123 0.8× 35 1.1k
Malia M. Edwards United States 21 736 1.3× 706 1.9× 122 0.6× 433 2.1× 163 1.1× 44 1.3k
Shunbin Xu United States 18 1.4k 2.5× 308 0.8× 167 0.8× 267 1.3× 107 0.7× 37 2.2k
Mercedes Salvador‐Silva United States 15 609 1.1× 631 1.7× 180 0.8× 157 0.8× 141 0.9× 22 1.0k
Haoliang Huang United States 17 516 0.9× 267 0.7× 250 1.2× 59 0.3× 79 0.5× 23 810
Takuji Kurimoto Japan 18 533 0.9× 410 1.1× 632 2.9× 163 0.8× 245 1.6× 65 1.3k
Matthew J. Brooks United States 20 1.0k 1.8× 251 0.7× 325 1.5× 88 0.4× 69 0.5× 37 1.2k
Frédéric Lebrun-Julien Switzerland 11 606 1.1× 226 0.6× 433 2.0× 57 0.3× 145 1.0× 12 1.0k
Fiona C. Mansergh Ireland 19 770 1.3× 393 1.1× 260 1.2× 157 0.8× 51 0.3× 36 1.2k

Countries citing papers authored by Samuel McLenachan

Since Specialization
Citations

This map shows the geographic impact of Samuel McLenachan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel McLenachan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel McLenachan more than expected).

Fields of papers citing papers by Samuel McLenachan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel McLenachan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel McLenachan. The network helps show where Samuel McLenachan may publish in the future.

Co-authorship network of co-authors of Samuel McLenachan

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel McLenachan. A scholar is included among the top collaborators of Samuel McLenachan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel McLenachan. Samuel McLenachan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Dan, Tina M. Lamey, Jennifer A. Thompson, et al.. (2024). Rapid Variant Pathogenicity Analysis by CRISPR Activation of CRB1 Gene Expression in Patient-Derived Fibroblasts. The CRISPR Journal. 7(2). 100–110. 4 indexed citations
2.
Pitout, Ianthe, Fred K. Chen, Samuel McLenachan, et al.. (2024). A Precision Therapy Approach for Retinitis Pigmentosa 11 Using Splice-Switching Antisense Oligonucleotides to Restore the Open Reading Frame of PRPF31. International Journal of Molecular Sciences. 25(6). 3391–3391. 5 indexed citations
3.
McAllister, Ian L., Sarojini Vijayasekaran, Samuel McLenachan, et al.. (2024). Cytokine Levels in Experimental Branch Retinal Vein Occlusion Treated With Either Bevacizumab or Triamcinolone Acetonide. Translational Vision Science & Technology. 13(6). 13–13.
4.
Wong, Elaine Y.M., Dan Zhang, Tina M. Lamey, et al.. (2024). Generation of two induced pluripotent stem cell lines from an Usher syndrome type 1B patient with the homozygous c.496del MYO7A variant. Stem Cell Research. 79. 103492–103492. 1 indexed citations
5.
Zhang, Dan, Leon M. Larcher, Tina M. Lamey, et al.. (2024). Derivation of two induced pluripotent stem cell lines from a healthy control subject. Stem Cell Research. 82. 103621–103621.
6.
Nguyen, Tu, Jarmon G. Lees, Jiang-Hui Wang, et al.. (2023). Knockout of AMD-associated gene POLDIP2 reduces mitochondrial superoxide in human retinal pigment epithelial cells. Aging. 15(6). 1713–1733. 2 indexed citations
7.
McLenachan, Samuel, et al.. (2023). Recent Therapeutic Progress and Future Perspectives for the Treatment of Hearing Loss. Biomedicines. 11(12). 3347–3347. 13 indexed citations
8.
Beasley, Aaron B., David B. Preen, Samuel McLenachan, Elin S. Gray, & Fred K. Chen. (2023). Incidence and Mortality of Conjunctival Melanoma in Australia (1982 to 2014). Investigative Ophthalmology & Visual Science. 64(14). 2–2. 2 indexed citations
9.
Carvalho, Lívia S., May T. Aung-Htut, Sue Fletcher, et al.. (2022). Pathogenesis and Treatment of Usher Syndrome Type IIA. Asia-Pacific Journal of Ophthalmology. 11(4). 369–379. 12 indexed citations
10.
Zhang, Dan, Tina M. Lamey, Jennifer A. Thompson, et al.. (2021). Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1. Stem Cell Research. 54. 102403–102403. 5 indexed citations
11.
McLenachan, Samuel, Dan Zhang, Xiao Zhang, et al.. (2021). Determinants of Disease Penetrance in PRPF31-Associated Retinopathy. Genes. 12(10). 1542–1542. 15 indexed citations
12.
Jeffery, Rachael C. Heath, May T. Aung-Htut, Samuel McLenachan, et al.. (2021). Stargardt disease and progress in therapeutic strategies. Ophthalmic Genetics. 43(1). 1–26. 27 indexed citations
13.
Zhang, Dan, Samuel McLenachan, Xiao Zhang, et al.. (2021). Generation of two induced pluripotent stem cell lines from a patient with recessive inherited retinal disease caused by compound heterozygous mutations in SNRNP200. Stem Cell Research. 51. 102154–102154. 2 indexed citations
14.
Zhang, Xiao, Dan Zhang, Jennifer A. Thompson, et al.. (2021). Gene correction of the CLN3 c.175G>A variant in patient‐derived induced pluripotent stem cells prevents pathological changes in retinal organoids. Molecular Genetics & Genomic Medicine. 9(3). e1601–e1601. 17 indexed citations
15.
Zhang, Dan, May T. Aung-Htut, Tina M. Lamey, et al.. (2021). Generation of two induced pluripotent stem cell lines from a patient with Stargardt disease caused by compound heterozygous mutations in the ABCA4 gene. Stem Cell Research. 54. 102448–102448. 2 indexed citations
16.
Zhang, Dan, Tina M. Lamey, Jennifer A. Thompson, et al.. (2020). Generation of two induced pluripotent stem cell lines from a patient with Stargardt Macular Dystrophy caused by the c.768G>T and c.6079C>T mutations in ABCA4. Stem Cell Research. 48. 101947–101947. 3 indexed citations
17.
Thompson, Jennifer A., Jason Charng, Samuel McLenachan, et al.. (2020). Phenotype–genotype correlations in a pseudodominant Stargardt disease pedigree due to a novel ABCA4 deletion–insertion variant causing a splicing defect. Molecular Genetics & Genomic Medicine. 8(7). e1259–e1259. 11 indexed citations
18.
Chen, Fred K., Xiao Zhang, Dan Zhang, et al.. (2018). Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G>A mutation in ceroid lipofuscinosis neuronal 3 (CLN3). Documenta Ophthalmologica. 138(1). 55–70. 17 indexed citations
19.
McLenachan, Samuel, et al.. (2013). Plant Hormones Increase Efficiency of Reprogramming Mouse Somatic Cells to Induced Pluripotent Stem Cells and Reduce Tumorigenicity. Stem Cells and Development. 23(6). 586–593. 8 indexed citations
20.
McLenachan, Samuel, et al.. (2012). Cyclin A 1 Is Essential for Setting the Pluripotent State and Reducing Tumorigenicity of Induced Pluripotent Stem Cells. Stem Cells and Development. 21(15). 2891–2899. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inge Van Hove Breakdown of academic impact, for papers by Zhongshu Tang Breakdown of academic impact, for papers by Malia M. Edwards Breakdown of academic impact, for papers by Shunbin Xu Breakdown of academic impact, for papers by Mercedes Salvador‐Silva Breakdown of academic impact, for papers by Haoliang Huang Breakdown of academic impact, for papers by Takuji Kurimoto Breakdown of academic impact, for papers by Matthew J. Brooks Breakdown of academic impact, for papers by Frédéric Lebrun-Julien Breakdown of academic impact, for papers by Fiona C. Mansergh
Rankless by CCL
2026